ITOS: iTeos Therapeutics Company Short-Term Debt
iTeos Therapeutics (ITOS) is implementing robotic stations for high-precision antibody selection, eliminating routine labor for scientists. The financial base relies on substantial payments from partners, as market pricing is currently absent and the metric stands at 0.00. This price chart demonstrates the asset's current dynamics. The business focuses on creating advanced cancer immunotherapy methods, planning revenue from the sale of agents that activate the body's defensive forces against tumors.
Metric breakdowns and analytics for iTeos Pharma (ITOS)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital iTeos Therapeutics|ITOS - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity iTeos Therapeutics|ITOS - Company Total Debt|Debt to Book Capitalization Ratio iTeos Therapeutics, Inc.|ITOS - Company Long-Term Liabilities|Company Current Liabilities iTeos Therapeutics|Quick Liquidity iteostherapeutics.com
- net income and valuation multiples indicators:
Initial company analysis:ITOS - iTeos Therapeutics, Inc.
Large-scale clinical trials of immuno-oncology drugs by iTeos Therapeutics (ITOS) require strict liquidity management to maintain operational resilience. This indicator measures the aggregate of liabilities with a maturity of up to one year, allowing the investor to assess the risk of breaching credit covenants and the issuer's financial discipline through an analysis of short-term debt volume.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|Upstream Bio Corp - Company Short-Term Debts|Short-Term Debt Volume Zenas Corp ZBIO|IMNM (Immunome, Inc.) - Company Current Liabilities|GOSS: Amount of Current Liabilities|KALV (KalVista Pharmaceuticals, Inc.) - Company Short-Term Debts|Short-Term Debt Septerna, Inc. SEPN|Company Short-Term Debt Pieris Pharmaceuticals Inc (PVLA)|SVRA - Short-Term Debt|Company Short-Term Debt Rigel Pharmaceuticals RIGL|Short-Term Debt Volume anaptysbio.com (ANAB)|ATXS: Company Current Liabilities|Company Short-Term Loans and Borrowings ENGN (enGene Holdings Inc)|RAPT (RAPT Therapeutics) - Company Current Liabilities|JBIO: Amount of Current Liabilities|ACRS (Aclaris Therapeutics) - Company Short-Term Debts|KYTX: Company Short-Term Loans and Borrowings|Company Short-Term Debts TLSA|CABA - Short-Term Debt|Company Short-Term Debt Ventyx Bio VTYX|Company Short-Term Loans and Borrowings THTX|Avalo Therapeutics, Inc - Company Short-Term Debts|ELDN - Company Short-Term Debts|Agenus Inc. (AGEN) - Company Short-Term Debt|Current Liabilities CLYM (Climb Bio Inc.)|ZURA (Zura Bio) - Company Short-Term Debts|Short-Term Debt aTyr Pharmaceuticals ATYR|Company Current Liabilities ADAG (Adagene)|Company Short-Term Debts ikenaoncology.com (IMA)|Shattuck Labs - Company Current Liabilities|Amount of Current Liabilities EQ (Equillium Inc)|Connect Pharma - Company Short-Term Debts|Short-Term Debt Volume Immunic, Inc. IMUX|ATRA: Company Short-Term Debts|Company Current Liabilities InflaRx|Company Short-Term Debt X4 Pharmaceuticals, Inc.|Adicet (ACET) - Short-Term Debt Volume|Company Short-Term Debts CELU|Short-Term Debt Volume INmune Bio Corporation|Barinthus Biotherapeutics - Company Current Liabilities|Amount of Current Liabilities KZR (kezarlifesciences.com)|SABS - Company Short-Term Debt|Short-Term Debt Akari Therapeutics PLC|enlivex.com (ENLV) - Company Short-Term Debt|QTTB - Short-Term Debt Volume|Company Short-Term Debt GeoVax Labs, Inc.|edesabiotech.com - Current Liabilities|Company Short-Term Debts IBIO|CARM (carismatx.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts XTLB (XTL Biopharmaceuticals, Ltd.)|Company Short-Term Debts Bolt Biotherapeutics Inc. BOLT|HCWB - Company Short-Term Debt|Company Short-Term Loans and Borrowings APVO (Aptevo Therapeutics)|AIM ImmunoTech Inc. (AIM) - Company Short-Term Debt|Company Current Liabilities Aditxt, Inc.|GRI (GRI Bio Corp) - Company Short-Term Debts|Company Short-Term Debts XORTX Corp|Company Current Liabilities HIND (Vyome Holdings Inc)|REVB (revbiosciences.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts INDP (Indaptus Therapeutics, Inc.)|Short-Term Debt Volume Scinai Immunotherapeutics Ltd (SCNI)|CALI - Company Short-Term Debt|Affimed (AFMD) - Company Current Liabilities|allakos.com (ALLK) - Company Short-Term Debt|Company Current Liabilities HOOKIPA Pharma|Company Current Liabilities IGMS|Company Short-Term Debts Ocean Biomedical Inc|Company Short-Term Debt TC BioPharm (Holdings) PLC (TCBP)|Third Harmonic Bio Inc - Company Short-Term Indebtedness